Regeneron · 6 days ago
Director, Global Development Strategic Partnerships
Regeneron Pharmaceuticals is seeking a Director of Global Development Strategic Partnerships to enhance their collaborations with external entities. The role involves identifying, executing, and managing strategic relationships to support the Global Clinical Development organization’s R&D objectives, while fostering internal capabilities and collaborative efforts across various business functions.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Partner and collaborate with multiple business functions (including, but not limited to: Research, Development, Commercial, Business Development, Site Operations, Vendor Management, Clinical Trial Management, Innovation, Project Management, Medical Affairs, and Strategic Alliances, Global Trial Optimization, etc)
Play a critical role in creating a long-term company-wide strategy on how best to leverage collaborations with external entities to address needs and opportunities to enable Regeneron to more effectively conduct clinical trials and translational and basic research
Drive the vetting and coordination associated with opportunities for partnership. When needed, coordinate with other internal experts for support
Coordinate the identification of new opportunities with new or existing partner organizations
Support the identification and evaluation of key external partners based on agreed upon corporate needs/gaps
Work cross-functionally to best leverage/prioritize the value of larger and more strategic partnerships
Manage and track external partnership opportunities, in collaboration with project management colleagues and other external-facing colleagues
Develop consistent channels for timely and productive communication with internal/external partners and work collaboratively with internal collaborators to ensure continuity of messaging/contact
Collaborate with Global Trial Optimization, evaluate and find opportunities for innovation, synergy and efficiency in new and existing partnerships
Qualification
Required
A minimum of a bachelor's degree
12+ years of relevant industry related experience
Ability to build consensus with leaders and colleagues to gain support for initiatives
Proven track record of developing and maintaining relationships with partners at all levels of the organization
Strong existing relationships and reputation within the life science industry, specifically with academic medical centers and large health systems
Previous experience in and deep understanding of the drug development process
Ability to manage and prioritize multiple tasks and projects with a sense of urgency and to navigate within a matrix organization
Experienced in planning and execution; thinks strategically and executes tactically in order to deliver positive results for the business
Strong business and financial management acumen
Demonstrated resiliency; able and willing to explore different paths to achieve an outcome
Outstanding verbal and written communication and presentation skills; ability to communicate accurately and concisely
Preferred
An advanced degree in a related field
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
2026-01-09
2026-01-08
Company data provided by crunchbase